Four faculty in the WDOM have received the ASCI Council Young Physician-Scientist Award. This prestigious award recognizes physician-scientists who are early in their first faculty appointment and have made notable achievements in their research.
In a collaborative study, investigators have implemented advanced technology and analytics to map, at single-cell resolution, the cellular landscape of diseased lung tissue in severe COVID-19 and other infectious lung diseases.
This exciting new program on COVID-19 for STEM students will cover many areas, including the dissemination of information about COVID-19 and vaccination for diverse communities, vaccine science, and approaches for community education.
Investigators found that patients with Crohn’s disease have an overabundance of an inflammation-producing gut bacteria. A metabolite produced by this bacteria interacts with the immune system cells in the lining of the intestine.
Dr. Leandro Cerchietti and colleagues have published a paper in Cancer Discovery that has revealed a critical connection between lymphoma tumors and their microenvironments, which consist of different ecosystems of cells and treatment responsiveness.
Dr. Ari Melnick and team have published a breakthrough finding in Nature Immunology that has identified Smc3 as a critical gene in the development of the body’s immune response (B cells).
Dr. Fernandez, formerly an Assistant Professor of Clinical Emergency Medicine in the WDOM, joined Emergency Medicine at Weill Cornell in 1987. An outstanding and beloved physician, he excelled at the highest level of excellence during his years with the WDOM and throughout his tenure in the Department of Emergency Medicine at Weill Cornell Medicine.
The awards are given to “promising early-career projects aimed at addressing unmet needs in cancer research.”
Results from an international Phase 3 clinical trial have led to the U.S. Food and Drug Administration’s approval of oral azacytidine (Onureg) as a maintenance therapy for AML, which is now being used as part of standard patient care.
The researchers analyzed data from the REGARDS Study, which tracked cardiovascular-related outcomes in over 20,000 people for a decade, to identify adverse social determinants of health that can lead to a higher likelihood of a fatal heart attack.
